CUVITRU (Immune Globulin Subcutaneous (Human))

**Product type:** Plasma Derivative

**Active ingredient:** HUMAN IMMUNOGLOBULIN G

**Strength:** 200 mg/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Takeda Pharmaceuticals America, Inc.

**Marketing category:** BLA (BLA125596)

**Pharmacologic class:** Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]